Aisha Lynn Siebert, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wasp Venoms | 3 | 2019 | 21 | 1.280 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2023 | 33 | 0.850 |
Why?
|
| Turner Syndrome | 1 | 2023 | 130 | 0.760 |
Why?
|
| Mesangial Cells | 1 | 2019 | 23 | 0.640 |
Why?
|
| Sorbitol | 1 | 2019 | 61 | 0.640 |
Why?
|
| Wasps | 1 | 2015 | 15 | 0.510 |
Why?
|
| Calreticulin | 1 | 2015 | 115 | 0.460 |
Why?
|
| Host-Parasite Interactions | 1 | 2015 | 303 | 0.430 |
Why?
|
| Sexual Development | 2 | 2023 | 39 | 0.420 |
Why?
|
| Androgen Antagonists | 2 | 2022 | 1412 | 0.400 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 1882 | 0.380 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 4892 | 0.350 |
Why?
|
| Prostatic Neoplasms | 3 | 2022 | 11097 | 0.340 |
Why?
|
| Biomedical Research | 2 | 2024 | 3464 | 0.320 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 11923 | 0.250 |
Why?
|
| Dementia | 1 | 2020 | 2741 | 0.250 |
Why?
|
| Physicians | 2 | 2024 | 4593 | 0.220 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2023 | 45 | 0.220 |
Why?
|
| Kidney | 1 | 2019 | 7063 | 0.220 |
Why?
|
| Gonads | 1 | 2023 | 109 | 0.210 |
Why?
|
| Penile Induration | 1 | 2021 | 17 | 0.190 |
Why?
|
| Traction | 1 | 2021 | 112 | 0.180 |
Why?
|
| Collagenases | 1 | 2021 | 221 | 0.180 |
Why?
|
| Depression | 1 | 2020 | 8234 | 0.180 |
Why?
|
| Semen Analysis | 1 | 2022 | 235 | 0.170 |
Why?
|
| Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) | 1 | 2019 | 11 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 18063 | 0.160 |
Why?
|
| Semen | 1 | 2022 | 349 | 0.160 |
Why?
|
| Aldehyde Reductase | 1 | 2019 | 69 | 0.160 |
Why?
|
| Phthalazines | 1 | 2021 | 397 | 0.150 |
Why?
|
| Genes, BRCA2 | 1 | 2021 | 591 | 0.150 |
Why?
|
| Cryopreservation | 1 | 2023 | 727 | 0.140 |
Why?
|
| Genes, BRCA1 | 1 | 2021 | 753 | 0.140 |
Why?
|
| Fructose | 1 | 2019 | 284 | 0.140 |
Why?
|
| Sarcophagidae | 1 | 2015 | 1 | 0.130 |
Why?
|
| Cell Count | 1 | 2019 | 1825 | 0.120 |
Why?
|
| Diptera | 1 | 2014 | 50 | 0.120 |
Why?
|
| Career Choice | 1 | 2020 | 769 | 0.110 |
Why?
|
| Minority Groups | 1 | 2020 | 1214 | 0.110 |
Why?
|
| Indoles | 1 | 2021 | 1836 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 1885 | 0.100 |
Why?
|
| DNA Repair | 1 | 2021 | 2050 | 0.100 |
Why?
|
| Cystectomy | 1 | 2016 | 603 | 0.100 |
Why?
|
| DNA Damage | 1 | 2021 | 2469 | 0.090 |
Why?
|
| Exosomes | 1 | 2016 | 417 | 0.090 |
Why?
|
| Students, Medical | 1 | 2024 | 1965 | 0.090 |
Why?
|
| Piperazines | 1 | 2021 | 2548 | 0.090 |
Why?
|
| Antigens, CD20 | 1 | 2011 | 199 | 0.090 |
Why?
|
| Aftercare | 1 | 2016 | 915 | 0.090 |
Why?
|
| Mutagens | 1 | 2010 | 181 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2021 | 3591 | 0.070 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2011 | 527 | 0.070 |
Why?
|
| Glucose | 1 | 2019 | 4341 | 0.070 |
Why?
|
| RNA Interference | 1 | 2015 | 2829 | 0.070 |
Why?
|
| Male | 10 | 2024 | 364203 | 0.070 |
Why?
|
| Humans | 14 | 2024 | 767040 | 0.060 |
Why?
|
| Chromosome Aberrations | 1 | 2010 | 1776 | 0.060 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2016 | 2186 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 26325 | 0.050 |
Why?
|
| Maternal Exposure | 1 | 2010 | 1096 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7435 | 0.050 |
Why?
|
| Sperm Count | 1 | 2022 | 227 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2016 | 3854 | 0.050 |
Why?
|
| Sperm Motility | 1 | 2022 | 262 | 0.040 |
Why?
|
| Organ Transplantation | 1 | 2011 | 1173 | 0.040 |
Why?
|
| Injections, Intralesional | 1 | 2021 | 280 | 0.040 |
Why?
|
| Research Personnel | 1 | 2024 | 589 | 0.040 |
Why?
|
| Mutation | 1 | 2023 | 30211 | 0.040 |
Why?
|
| Animals | 4 | 2021 | 168965 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 13650 | 0.040 |
Why?
|
| Air Pollutants | 1 | 2010 | 2920 | 0.030 |
Why?
|
| Child | 2 | 2023 | 80771 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2024 | 1227 | 0.030 |
Why?
|
| Pupa | 1 | 2014 | 42 | 0.030 |
Why?
|
| Androgens | 1 | 2022 | 1281 | 0.030 |
Why?
|
| Critical Pathways | 1 | 2016 | 476 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 2022 | 2463 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2016 | 2551 | 0.030 |
Why?
|
| United States | 1 | 2020 | 72971 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2472 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 754 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 8535 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2024 | 4526 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2016 | 5022 | 0.020 |
Why?
|
| Female | 5 | 2024 | 396660 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 2040 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 3427 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4280 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2016 | 2978 | 0.020 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2011 | 616 | 0.010 |
Why?
|
| Pandemics | 1 | 2024 | 8736 | 0.010 |
Why?
|
| Cell Movement | 1 | 2016 | 5203 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9410 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2010 | 1361 | 0.010 |
Why?
|
| Cell Line | 1 | 2016 | 15567 | 0.010 |
Why?
|
| Quality of Life | 1 | 2022 | 13485 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2016 | 3792 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 8628 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13646 | 0.010 |
Why?
|
| Adult | 2 | 2024 | 223317 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2011 | 10092 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2010 | 4546 | 0.010 |
Why?
|
| Prognosis | 1 | 2011 | 29963 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 36485 | 0.000 |
Why?
|
| Pregnancy | 1 | 2010 | 30238 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2011 | 42606 | 0.000 |
Why?
|
| Young Adult | 1 | 2011 | 59980 | 0.000 |
Why?
|
| Aged | 1 | 2016 | 171319 | 0.000 |
Why?
|
| Adolescent | 1 | 2011 | 89046 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2011 | 81659 | 0.000 |
Why?
|
| Middle Aged | 1 | 2016 | 223233 | 0.000 |
Why?
|